Lysophospholipid acyltransferases (LPATs) incorporate fatty acyl chains into phospholipids via a coenzyme A (CoA)-dependent mechanism, and are important in remodeling phospholipids to generate the molecular species of phospholipids found in cells. These enzymes use one lysophospholipid and one acyl-CoA ester as substrates.
Introduction
Two distinctive branches of anabolic pathways dictate the quantity and diversity of phospholipids synthesized across multiple phyla of organisms. One branch, known as the de novo route, relies upon the specificity of glycerophosphate-and acylglycerophosphate-acyltransferases to dictate the fatty acyl composition of downstream phospholipid end products (Kennedy Pathway) (1) . A second branch remodels products of the first branch, usually via the sequential action of a phospholipase and a lysophospholipid acyltransferase (LPAT), producing a different repertoire of phospholipid molecular species (Lands Cycle) (2) . Data from yeast clearly indicated that the remodeling pathway can operate independently of the de novo pathway when a significant source of extracellular lysophospholipids is provided (3, 4) .
Although the initial enzymatic characterization of the remodeling pathway occurred nearly 50 years ago, little progress was made to identify the genes that encoded these enzymes until various complete genomes were sequenced and a collection of candidate genes and cDNAs were empirically tested for their enzymatic functions. Since 2005, several groups have performed extensive analysis of the function of these enzymes, and discovered that LPATs belong to two different protein families, represented by the lysophosphatidic acid acyltransferases (LPAATs) and the membrane bound O-acyltransferases (MBOATs) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . These families both contain membranebound proteins that have not been purified from tissues (17) , but their encoding cDNAs have been cloned and expressed in a variety of host cells including yeast (10, 13, 18) .
Enzyme activity assays have been a traditional biochemical means by which to assess the presence of a particular protein in the biological extract and providing insight into the overall performance of this enzyme in terms of synthetic capacity and substrate specificity. LPAT activity assays are often performed by exposing a tissue extract, containing the enzyme of interest, to a pair of pure substrates (one lysophospholipid and one acyl-CoA ester), and measuring the reaction rate parameters for substrate conversion to product. The results of this experiment are then compared to results from an identical set of experiments, but with a different substrate. Eventually, a picture emerges of preferred substrates. Thus, many substrates need to be individually studied, and a concern with this approach is that any competition between substrates for the enzyme is not revealed.
We present here an alternative biochemical assay that provides a mixture of substrates to the microsomal extract. Unique phospholipid products of unique masses are identified and quantitated using liquid chromatography tandem mass spectrometry.
This strategy of a substrate choice enzymatic assay is particularly useful for study of the LPATs since these enzymes employ two substrates to make the final phospholipid product. Therefore, with two substrates this greatly expands the total number of analyses that need to be carried out by this single substrate enzyme activity strategy if a complete picture of enzymatic activity is desired. This substrate choice enzyme activity assay presents microsomal enzymes with a mixture of different substrates in the same reaction, with the profile of product abundance indicating reflecting substrate preference. While exact information may somewhat differ between these two assay approaches, this choice assay does reveal potential for product formation when specific substrates are added to the tissue extract. This substrate choice assay is easily carried out due to advances in electrospray tandem mass spectrometry. In this report, we were pelleted at 300 x g, resuspended in homogenization buffer (50 mM Tris-HCl, pH 7.4, 250 mM sucrose, 1 mM EDTA, 20% (w/v) glycerol, and protease inhibitor cocktail), and lysed using a Sonics Vibra-Cell probe sonicator (Newtown, CT). Whole cells and cellular debris were pelleted at 12,000 x g for 20 min at 4 °C. The supernatant was transferred to an ultracentrifuge tube and centrifuged at 100,000 x g for 60 min at 4 °C.
The microsomal pellet was resuspended in assay buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA), protein amount was determined using the bicinchoninic acid assay (Thermo Scientific, Rockford, IL), and microsomes were stored at -20 °C until used. were also measured for each phospholipid class to check for possible changes in endogenous microsomal phospholipids during the incubation period.
The effectiveness of normal-and reverse-phase liquid chromatography was evaluated to resolve both endogenous and newly synthesized phospholipids, which were then detected with a triple quadrupole mass spectrometer operated in the MRM mode. Typical reverse-phase and normal-phase chromatography profiles for the products of the assay are presented in Supplementary Fig. 1 were not obscured by high background.
Quantitation of each of the phospholipid reaction products was performed by calculating the ratio of the integrated area of the phospholipid product peak (analyte) to that of the corresponding internal standard (IS). Then, reference standard dilution curves were used to calculate the amount of phospholipid product made, as previously Previous assays to test LPAT activity have used high levels of substrates with long incubation times to assay LPAT activity. In testing the dual substrate choice assay, reaction conditions were optimized to ensure that they were within the linear range, to better appreciate the substrate preferences of the LPATs present in the sample.
Four major variables that dictate product formation were analyzed, namely time, chain lysophospholipids, single substrate assays were performed using more common lysophospholipids (Supplemental Figure 4) . These data confirm that the use of 17:1-lysophospholipid in a dual choice setting recapitulates data obtained in the traditional enzymatic assays with natural lysophospholipid species.
An alternative presentation of the data makes it easier to illustrate phospholipid class specificity using each of the acyl chains ( Figure 3 ). Even though this experiment employed a 10-min incubation, the apparent substrate preference of the combined LPAT activities in the microsomes remained very similar to that presented in Figure 2 , 
Dual substrate choice assay comparison to alternative LPAT assays
The dual substrate choice assay was compared to three other LPAT assays. Importantly, the substrate preference exhibited for arachidonate incorporation into the different phospholipids was essentially identical either using either a series of single substrate assays (Fig. 4B) or the dual substrate choice (Fig. 4C ). This indicates that the availability of a variety of substrates does not obscure the substrate preference of the enzymes present in the microsomes and supports the usefulness of this assay as a valid alternative to individual assays for each substrate.
Dual substrate choice as a tool to detect changes in LPAT activity
The dual substrate choice assay was used to detect changes in a specific LPAT 
Discussion
Glycerophospholipids are the major components of all biological membranes and specific molecular species within this family determine properties such as membrane fluidity and curvature. Glycerophospholipid molecular species composition also affects the activity of membrane-associated enzymes and the production of lipid mediators of inflammation (25). The acyl chain composition of phospholipids is the result of a combination of multiple enzymatic activities, including phospholipases, acyl CoA synthetases, and lysophospholipid acyltransferases (LPATs), which lead to the large diversity of phospholipid species necessary for different membrane characteristics.
LPATs have been studied since the 1950s, by employing assays in which the enzymatic activity was usually determined using substrates consisting of a single lysophospholipid and one fatty acyl-CoA ester. In the last decade, several LPATs, belonging to two distinct protein families, have been described and characterized.
Detailed enzymatic analysis of these proteins, after cloning and expression of the corresponding genes, has revealed a wide variety of activities for specific lysophospholipid and fatty acyl CoA substrates, sometimes catalyzed by the same enzyme, which makes single substrate analysis less useful for characterizing biological In this report, absolute amounts of the phospholipid products were determined by creating and applying standard curves for each of the six phospholipid classes measured. Because ionization efficiencies can differ greatly between the different phospholipid classes, it was important to use separate internal standards and standard curves for each phospholipid class. An additional discovery from our experimentation was the finding that normalization of the activity data can be achieved by measuring endogenous molecular species within each class, since the absolute quantity of endogenous phospholipid was a direct measure of the quantity of microsomal preparation taken for assay. This study showed excellent correlation of the 16:0/18:1-and 18:1/18:1-phospholipids with the microsomal protein levels.
The microsomal membranes from RAW 264.7 cells contained a mixture of different enzymes, thus the integrated reacylation activities observed in the dual choice assay reflect this complexity. However, it was possible to identify products that implied the presence of particular LPAT isoforms. In many cases the phospholipids produced in the reaction are not the most abundant phospholipids in the RAW 264.7 cell. A good example of this is 22:6 containing PE and PS. No LPAT activity has been described at this point that can catalyze the formation of these phospholipids. It is possible in other biological systems that there is an LPAT that can catalyze these reactions, but we do not know precisely which proteins are involved. An alternative explanation of some abundant phospholipids not being formed in this reaction would be that it takes multiple different enzyme subtypes to catalyze these reactions, for instance involving CoA-independent transacylases. Since we are using microsomal extracts and incubating the reaction for a short period of time, we may be missing the formation of these lipids which would occur in a whole cell system and/or at longer time points.
The characteristic LPAT activity of LPCAT3/MBOAT5 was suggested by specific newly synthesized arachidonoyl-containing phospholipids by the microsomal preparation from the RAW 264.7 cells. This evidence was confirmed by the dramatic reduction of 20:5, 20:4, and 18:2-containing PC, PE and PS products when LPCAT3 expression was specifically reduced by using the corresponding shRNA construct, whereas no change was observed in the majority of the other phospholipid products.
This illustrates the possibilities of the assay in detecting changes in LPAT activity across different cells or experimental conditions. It provides a less targeted approach than the traditional biochemical assays, potentially very useful where the activity or expression of individual acyltransferases have not previously been shown to change.
Use of the dual choice assay also provided evidence for additional acyltransferase enzyme activities that have not been identified. The incorporation of stearoyl chains into PS, PI, and PC was unexpectedly high, but an acyltransferase catalyzing this reaction has not been reported. It is also uncertain which enzyme transfers 22:6 chains into PC and PI, although low levels of these activities have been reported for LPAAT3. Thus, by probing for multiple acyltransferase activities in one assay, employing large combinations of substrate choices, it is now possible to detect novel enzymes with LPAT activity.
The dual choice assay provides a facile and more extensive biochemical approach to studying acyltransferase activity. This novel biochemical technique introduces substrate competition, which provides insight into the preference of substrates, since most biological systems have multiple fatty acyl CoA esters and lysophospholipids present and is readily implemented using tandem mass spectrometry. Microsomes from RAW 264.7 cells were used to assay for LPAT activity using a mix of six lysophospholipids and eight acyl-CoA esters as described in the Methods section. 
